Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose M Rubio

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusJoseph F Goldberg, Holly A Swartz, Roger S McIntyre, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusJoseph F Goldberg, Holly A Swartz, Roger S McIntyre, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Pageof 8